Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

PWRM, DLKM, TRIT, SPSC, ORBK- Stock Reports! from Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

________________________________________

Power3 Medical Products, Inc. (OTC:PWRM)

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, today announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.

In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3’s depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.

“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

International, breast cancer consists of 10.4% in all cancer incidence among the ladies, defining it as the most common method of non-skin cancer in females and then the 5th most typical reason for cancer death. In 04, cancer of the breast induced 519,000 fatalities globally (7% connected with cancer deaths; practically 1% of all deaths). Breast cancers is about one hundred times more widespread in women than in men, even though men generally have poorer success on account of delays in medical diagnosis.

Parkinson’s disease (PD) is part of several disorders called motor system disorders, that are the effect of the decline of dopamine-producing brain cells. Some primary symptoms of PD tend to be tremor, or shaking in hands, arms, legs, jaw, and face; stiffness, as well as tightness of the limbs and trunk; bradykinesia, or slowness to move; and postural instability, or impaired equilibrium and also balance. As far as symptoms become more pronounced, patients sometimes have challenges walking, talking, or finishing some other rather simple tasks.

Alzheimer’s worsens after a while. Alzheimer’s is some sort of progressing ailment, in which symptoms slowly progress over a period of time. In its early stages, forgetfulness is slight, however with late-stage Alzheimer’s disease, people today will not be able to carry on a conversation as well as react to their natural environment. Alzheimer’s disease is considered the 6th leading source of dying within the united states. Those that have Alzheimer’s disease live life typically 8 years after their signs or symptoms come to be obvious to many others, but yet survival can vary from three to 20 years, based on years of age along with other health conditions.

Douglas Lake Minerals Inc. (OTC:DLKM)

Douglas Lake Minerals Inc. has filed a Canadian National Instrument 43-101 Standards for Disclosure of Mineral Projects (”NI 43-101) Technical Report (the “Technical Report”) for its Handeni Project. DLKM’s 100% owned Handeni Project consists of four prospecting licenses covering approximately 800 square kilometers in the newly developing goldfields of Eastern Tanzania. Douglas Lake filed the Technical Report with the British Columbia Securities Commission via the System for Electronic Document Analysis and Retrieval (SEDAR).

The Technical Report was prepared by Dr. Reyno Scheepers, Ph.D., Pr.Sci.Nat., a South African based consulting geologist and a director of DLKM who fulfills the requirements to be a ‘Qualified Person’ for the purposes of NI 43-101.

“The scale of work covered by the Technical Report has significantly advanced Douglas Lake’s Handeni Project,” Harp Sangha, Chief Executive Officer comments, “We now have a number of very exciting gold targets which we are a priority for us to follow up with further exploration in 2011.”

The Technical Report details the results of exploration activities conducted by IPP Resources, the previous holding company of the area. Extensive geophysical and geologic work was conducted over several field seasons from 2008. The work included prospecting, rock and soil sampling, and a ground magnetic survey. All geochemical analytical work was conducted by internationally accredited labs, SGS Laboratories and/or Humac Laboratories in Mwanza, Tanzania.

Tri-Tech Holding, Inc. (Nasdaq:TRIT) announced that BSST, its subsidiary, has signed a $2.17 million contract with Shaanxi Yanchang Petroleum (Group) Co., Ltd. (Yanchang) to construct the Yan'an Emergency Command and Control Center. According to the contract, BSST will construct a Command and Control System for Yanchang. The system will connect Yanchang Group with its production centers, subsidiaries and branches, with the aim to improve the transfer of data, images and videos among the units connected to the system. BSST shall procure all the equipment of the system, and provide the system engineering, integration, installation and debugging services to Yanchang. The system is expected to be fully completed in May 2011.
Tri-Tech Holding Inc. develops and implements integrated software and hardware solutions to assist Chinese government entities monitor and manage natural and municipal water supplies.

SPS Commerce, Inc. (Nasdaq:SPSC) a leading provider of on-demand supply chain management solutions, announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2010 after the market close on Wednesday, February 9, 2011. SPS Commerce will host a call to discuss the results at 3:30 p.m. Central Time (4:30 p.m. Eastern Time) on the same day. To access the call, please dial (877) 312-7508. A live webcast of the call will also be available at www.investors.spscommerce.com under the Events and Presentations menu. An audio replay will be available between 6:30 p.m. CT February 9, 2011 and 10:59 p.m.
SPS Commerce, Inc. provides on-demand supply chain management solutions worldwide. It offers integration, collaboration, connectivity, visibility, and data analytics over the Internet using a software-as-a-service model.

Orbotech Ltd. (Nasdaq:ORBK) announced at the Needham Conference certain of its preliminary estimated consolidated financial results for the year ended December 31, 2010 and its 2011 financial outlook. Orbotech estimates that its revenues for 2010 totaled approximately $525-$530 million, compared to $373.9 million recorded during 2009, and that its gross margin for 2010 will be approximately 41% compared to 38% in 2009. Orbotech also announced that it expects its revenues for 2011 to be approximately $560 million. This reflects Orbotech’s belief in the continued strength in the overall business environment. Due to the realization of benefits from our actions to achieve operating leverage, Orbotech expects a GAAP net margin of approximately 10% in 2011, compared to approximately 6% in 2010.
Orbotech Ltd., together with its subsidiaries, engages in the design, development, manufacture, marketing, and service of production solutions for specialized applications in the supply chain of the electronics industry worldwide.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

________________________________________

Be Sure To Visit stock-pr.ning.com

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.